Found: 5
Select item for more details and to access through your institution.
A Risk Model for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer: An Evidence-Based Proposal for Patient Selection.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2012, v. 19, n. 2, p. 597, doi. 10.1245/s10434-011-1873-2
- By:
- Publication type:
- Article
Surgery in Recurrent Ovarian Cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2006, v. 13, n. 12, p. 1702, doi. 10.1245/s10434-006-9058-0
- By:
- Publication type:
- Article
Prospective Multicenter Randomized Phase III Study of Weekly versus Standard Docetaxel (D2) for First-Line Treatment of Metastatic Breast Cancer.
- Published in:
- Oncology, 2011, v. 79, n. 3/4, p. 197, doi. 10.1159/000320640
- By:
- Publication type:
- Article
Prospective Multicenter Randomized Phase III Study of Weekly versus Standard Docetaxel plus Doxorubicin (D4) for First-Line Treatment of Metastatic Breast Cancer.
- Published in:
- Oncology, 2011, v. 79, n. 3/4, p. 204, doi. 10.1159/000320625
- By:
- Publication type:
- Article
Reduced Incidence of Severe Palmar-Plantar Erythrodysesthesia and Mucositis in a Prospective Multicenter Phase II Trial with Pegylated Liposomal Doxorubicin at 40 mg/m Every 4 Weeks in Previously Treated Patients with Metastatic Breast Cancer.
- Published in:
- Oncology, 2006, v. 70, n. 2, p. 141, doi. 10.1159/000093005
- By:
- Publication type:
- Article